miércoles, 18 de diciembre de 2019

STAT Plus: Breast cancer drug picked up by AstraZeneca shrinks tumors in majority of women with common tumor By MATTHEW HERPER

https://www.statnews.com/2019/12/11/breast-cancer-drug-picked-up-by-astrazeneca-shrinks-tumors-in-majority-of-women-in-clinical-study/?utm_source=STAT+Newsletters&utm_campaign=84b584116a-Cancer_Briefing&utm_medium=email&utm_term=0_8cab1d7961-84b584116a-149692869
Cancer Briefing

STAT Plus: Breast cancer drug picked up by AstraZeneca shrinks tumors in majority of women with common tumor

By MATTHEW HERPER

ANNIE CAVANAGH/WELLCOME
The new drug, trastuzumab deruxtecan, was tested in a clinical trial of 184 breast cancer patients whose tumors tested positive for a marker called HER2.

No hay comentarios: